-
ARTIFICIAL INTELLIGENCE (AI) ACROSS THE PRO LIFECYCLE: EVIDENCE AND EXPERT PERSPECTIVES ON OPPORTUNITIES AND CHALLENGES
Aug 11, 2026, 17:15 PM -
VALIDATION OF AN ALGORITHM TO IDENTIFY PROGRESSIVE PULMONARY FIBROSIS USING THE CANADIAN REGISTRY FOR PULMONARY FIBROSIS
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF LONG VERSUS SHORT PERIPHERAL VENOUS CATHETERS: A BUDGET IMPACT ANALYSIS IN HOSPITALIZED PATIENTS
Aug 11, 2026, 17:15 PM -
EMPIRICAL EVALUATION OF ACCESS-BASED PRICING USING A MULTI-COHORT STUDY OF EUROPEAN MEDICINAL PRODUCTS
Aug 11, 2026, 17:15 PM -
ORPHAN DRUGS, HTA UNCERTAINTY AND ACCESS INEQUALITIES: A COMPARATIVE ANALYSIS BETWEEN FRANCE AND GERMANY
Aug 11, 2026, 17:15 PM -
RETHINKING ECONOMIC MODELING IN ORGAN TRANSPLANTATION: A NEW CONCEPTUAL MODEL FOR COST-EFFECTIVENESS ANALYSIS
Aug 11, 2026, 17:15 PM -
SYNTHETIC SWEDISH CANCER REGISTRY DATA FOR HEALTH ECONOMIC RESEARCH AND INTERACTIVE DECISION SUPPORT
Aug 11, 2026, 17:15 PM -
SAME EVIDENCE, DIFFERENT PRICES? A COMPARATIVE ANALYSIS OF HTA OUTCOMES AND PRICING DYNAMICS ACROSS NICE AND ICER
Aug 11, 2026, 17:15 PM -
BUILDING TRUST: TRANSPARENCY AND STAKEHOLDER PARTICIPATION IN EU HTA
Aug 11, 2026, 17:15 PM -
EVOLVING CODING PRACTICES FOR PRIMARY IGA NEPHROPATHY IN GERMAN CLAIMS DATA: EVIDENCE FROM 2022-2024
Aug 11, 2026, 17:15 PM -
GOVERNANCE AND PRIORITIZATION FRAMEWORKS FOR EQUITABLE ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES IN THE MENA REGION: A CONSENSUS-DRIVEN APPROACH
Aug 11, 2026, 17:15 PM -
MAPPING PATIENT EXPERIENCES WITH GLP-1 RECEPTOR AGONISTS TO THE EQ-5D-5L FRAMEWORK USING ONLINE COMMUNITY FORUMS
Aug 11, 2026, 17:15 PM -
A LARGE LANGUAGE MODEL PIPELINE FOR RAPID QUALITATIVE RE-ANALYSIS OF WITHIN-TRIAL PATIENT INTERVIEWS: A HEALTH-RELATED QUALITY-OF-LIFE CASE STUDY
Aug 11, 2026, 17:15 PM -
ALIGNING TARGET PRODUCT PROFILES WITH HTA REQUIREMENTS THROUGH AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEWS: A CONCEPTUAL FRAMEWORK
Aug 11, 2026, 17:15 PM -
PRESCRIPTION TRENDS AND GENERIC MARKET SHARE OF HEPARINOID PREPARATIONS IN JAPAN FROM FY2014 TO FY2024: A LONGITUDINAL CLAIMS DATABASE STUDY
Aug 11, 2026, 17:15 PM -
OPTIMIZING GERIATRIC MEDICATION MANAGEMENT: INTERPLAY BETWEEN POLYPHARMACY, COMORBIDITY BURDEN, AND PATIENT PERSPECTIVES IN A PAKISTANI TERTIARY-CARE SETTING
Aug 11, 2026, 17:15 PM -
FROM CONVENTIONAL SYSTEMATIC LITERATURE REVIEWS TO LIVING EVIDENCE REVIEWS: A GENERATIVE AI-FRAMEWORK FOR CONTINUOUS EVIDENCE SURVEILLANCE AND REVIEW MAINTENANCE
Aug 11, 2026, 17:15 PM -
PHONE-BASED ASSESSMENT OF THE INCAT DISABILITY SCALE IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY(CIDP) - ASPECTS OF VALIDITY AND RELIABILITY, AND CONGRUENCE WITH SITE-BASED ASSESSMENT
Aug 11, 2026, 17:15 PM -
SOCIOECONOMIC VALUE OF IMMUNOTHERAPY AND TARGETED THERAPY IN ADJUVANT AND METASTATIC MELANOMA IN BULGARIA
Aug 11, 2026, 17:15 PM -
FIRST-LINE PERTUZUMAB-BASED TREATMENT FOR HER2-POSITIVE METASTATIC BREAST CANCER IN FRANCE: A FRENCH NATIONAL HEALTH DATA SYSTEM (SNDS) ANALYSIS
Aug 11, 2026, 17:15 PM
